A recently approved drug has shown promise in reducing heart attacks and strokes in patients with type 2 diabetes and kidney ...

Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more ...

Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.

Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab ...

The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...

The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia and partners.

Say Global Access To Oxygen, Highly Inequitable, Causing Widespread Suffering, Deaths … 400 Million Children, Adults Require Medical Oxygen Yearly … Urge Countries To Develop, Invest In National ...

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...